Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 818 of 1,261

  1. US 8715686

    Conformationally stabilized HIV envelope immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted

  2. US 8716294

    Methods for treating inflammatory conditions

    Melior Discovery, Inc. · Granted May 6, 2014 · Expires May 1, 2034

    granted

  3. US 8716321

    Methods for dosing an orally active 1,2,4-oxadiazole

    PTC THERAPEUTICS, INC. · Granted May 6, 2014 · Expires May 1, 2034

    granted

  4. US 8716338

    Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted May 6, 2014 · Expires May 1, 2034

    granted

  5. US 8716265

    4-quinolinemethanols as anti-malarial agents

    Jenrin Discovery, LLC · Granted May 6, 2014 · Expires May 1, 2034

    granted

  6. US 8709464

    Porous objects having immobilized encapsulated biomolecules

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  7. US 8709995

    Method for eliciting an immune response to human telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  8. US 8710081

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  9. US 8710030

    Phosphonate compounds

    The Regents of the University of California · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  10. US 8710026

    MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  11. US 8710004

    Stable liquid VEGF antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  12. US 8709784

    Use of Lactobacillus for liver protection

    China Medical University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  13. US 8710075

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  14. US 8710064

    2-aryl-4-quinazolinones and their pharmaceutical compositions

    China Medical University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  15. US 8710185

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  16. US 8709391

    Family of pain producing substances and methods to produce novel analgesic drugs

    The Board of Regents of the University of Texas System · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  17. US 8710031

    Compounds for nonsense suppression and methods for their use

    PTC THERAPEUTICS, INC. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  18. US 8709433

    Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  19. US 8709342

    Antimicrobial flush solutions

    The Board of Regents of the University of Texas System · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  20. US 8709417

    Combination immunotherapy for the treatment of cancer

    BOARD OF REGENTS · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  21. US 8709452

    Synthetic bone grafts

    The Regents of the University of California · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  22. US 8710017

    Human and mouse targeting peptides identified by phage display

    The Board of Regents of the University of Texas System · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  23. US 8709444

    Live-attenuated compositions for bacterial infections

    Northwestern University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  24. US 8709476

    Compositions of quaternary ammonium compounds containing bioavailability enhancers

    Supernus Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.